KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Equity Income (2016 - 2025)

Historic Equity Income for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $8.0 million.

  • Quest Diagnostics' Equity Income rose 3333.33% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 8181.82%. This contributed to the annual value of $19.0 million for FY2024, which is 2692.31% down from last year.
  • As of Q3 2025, Quest Diagnostics' Equity Income stood at $8.0 million, which was up 3333.33% from $9.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Equity Income high stood at $31.0 million for Q1 2022, and its period low was $3.0 million during Q4 2022.
  • Moreover, its 5-year median value for Equity Income was $8.0 million (2023), whereas its average is $11.2 million.
  • As far as peak fluctuations go, Quest Diagnostics' Equity Income crashed by 8800.0% in 2022, and later soared by 16666.67% in 2023.
  • Over the past 5 years, Quest Diagnostics' Equity Income (Quarter) stood at $25.0 million in 2021, then plummeted by 88.0% to $3.0 million in 2022, then surged by 166.67% to $8.0 million in 2023, then tumbled by 37.5% to $5.0 million in 2024, then surged by 60.0% to $8.0 million in 2025.
  • Its Equity Income stands at $8.0 million for Q3 2025, versus $9.0 million for Q2 2025 and $18.0 million for Q1 2025.